Dillard's reports results for quarter ending Nov. 1

Dillard’s, Inc. filed a current report to note that it has released its latest operating results.

Rhea-AI Filing Summary

Dillard’s, Inc. filed a current report to note that it has released its latest operating results. On November 13, 2025, the company issued a press release announcing financial results for the 13- and 39-week periods ended November 1, 2025, and furnished that release as an exhibit to this report. The filing is primarily procedural, directing investors to the accompanying press release for detailed revenue and profit figures.

Insights

Equity research analyst

Dillard’s 8-K simply furnishes its latest quarterly results press release.

Dillard’s, Inc. used this 8-K to formally furnish a press release covering results for the 13- and 39-week periods ended November 1, 2025. Item 2.02 filings like this are a standard way for companies to distribute earnings information broadly and ensure it is incorporated into the public disclosure record.

The absence of detailed figures in this excerpt means the key takeaways for revenue, margins, and profitability are contained in Exhibit 99.1 rather than the body of the report. From a process standpoint, this is a routine disclosure rather than a standalone strategic action, and the investment impact depends entirely on the financial data and commentary in the attached press release.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Dillard’s (DDS) disclose in this 8-K filing?

The company reported that it issued a press release on November 13, 2025, announcing financial results for the 13 and 39 weeks ended November 1, 2025.

Which periods do the Dillard’s (DDS) results in this filing cover?

The results cover the 13-week and 39-week periods ended November 1, 2025.

Where can investors find the detailed Dillard’s (DDS) financial results?

Detailed results are included in the press release furnished as Exhibit 99.1 to this report.

What is the main purpose of this Dillard’s (DDS) 8-K?

The main purpose is to furnish the company’s earnings press release for the 13 and 39 weeks ended November 1, 2025, under Item 2.02 Results of Operations and Financial Condition.

Who signed the Dillard’s (DDS) 8-K report?

The report was signed on behalf of Dillard’s, Inc. by Phillip R. Watts, Senior Vice President, Co-Principal Financial Officer and Principal Accounting Officer, and Chris B. Johnson, Senior Vice President and Co-Principal Financial Officer.

Which Dillard’s (DDS) security is listed in this filing?

The filing lists Dillard’s Class A Common Stock, which trades on the New York Stock Exchange under the symbol DDS.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/13/2025 - 04:13 PM Learn about SEC filing dates

0000028917false00000289172025-11-132025-11-13

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

​

FORM 8-K

​

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 13, 2025

​

Dillard’s, Inc.

(Exact name of registrant as specified in its charter)

​

Texas

(State or other jurisdiction of incorporation)

​

​	​	​
1-6140		71-0388071
(Commission File Number)	​	(IRS Employer Identification No.)
​	​	​
1600 Cantrell Road Little Rock, Arkansas	​	72201
(Address of principal executive offices)	​	(Zip Code)

​

(501) 376-5200

(Registrant’s telephone number, including area code)

​

Not Applicable

(Former name or former address, if changed since last report.)

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

​

​	​	​
☐		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
​	​	​
☐	​	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
​	​	​
☐	​	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
​	​	​
☐	​	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Securities registered pursuant to Section 12(b) of the Act:

​

​	​	​
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A Common Stock	DDS	New York Stock Exchange

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

​

Emerging growth company   ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

​

​

​

Item 2.02Results of Operations and Financial Condition.

On November 13, 2025, the registrant issued a press release announcing results for the 13 and 39 weeks ended November 1, 2025. A copy of the press release is furnished as Exhibit 99.1 to this current report and is incorporated herein by reference.

​

Item 9.01Financial Statements and Exhibits.

​

Exhibit No.		Description
​	​	​
99.1	​	Press Release dated November 13, 2025, announcing results for the 13 and 39 weeks ended November 1, 2025.
​	​	​
104	​	Cover Page Interactive Data File (embedded within the Inline XBRL Document)

​

​

​

​

​

​

​

​

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

​

​	​	​	​	​
​	​		​	DILLARD’S, INC.
​	​	​	​	​
Date:	November 13, 2025	​	By:	/s/ Phillip R. Watts
​	​	​	Name:	Phillip R. Watts
​	​	​	Title:	Senior Vice President, Co-Principal Financial Officer and Principal Accounting Officer
​	​	​	​	​
​	​	​	By:	/s/ Chris B. Johnson
​	​	​	Name:	Chris B. Johnson
​	​	​	Title:	Senior Vice President and Co-Principal Financial Officer

​

​

​

​